During the past decade, Orange Regional Medical Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 37 clinical trials were completed, i.e. on average, 308.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 16 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Orange Regional Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 22 trials, followed by "SWOG Cancer Research Network" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Nuo Therapeutics" with 3 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orange Regional Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Orange Regional Medical Center" are "Recurrent Squamous Cell Lung Carcinoma" (5 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (4 trials), "Breast Cancer" (3 trials), "Clear Cell Renal Cell Carcinoma" (3 trials) and "Recurrent Melanoma" (3 trials). Many other conditions were trialed in "Orange Regional Medical Center" in a lesser frequency.

Most popular intervention types in "Orange Regional Medical Center" are "Drug" (41 trials), "Other" (33 trials), "Biological" (17 trials), "Device" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (21 trials), "Quality-of-Life Assessment" (8 trials), "Bevacizumab" (6 trials), "Paclitaxel" (6 trials) and "placebo" (6 trials). Other intervention names were less common.

The vast majority of trials in "Orange Regional Medical Center" are 40 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Orange Regional Medical Center". undefined are not yet recruiting, 1 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Orange Regional Medical Center, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Orange Regional Medical Center, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".